Tocilizumab resulted in improvement in skin scores, although differences did not reach statistical significance, and there was no significant difference in pruritus between groups [ 19 ].
← all excerpts
Pruritus associated with systemic sclerosis: a systematic review of treatment-based clinical trials.
1
—
—